0.40
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ClouDr Group
Its shares trade on HKEX under the ticker 9955.HK. It has been listed since 6 July 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.62bn and a net loss of CN¥924.2m. At that date it held total assets of CN¥1.68bn and shareholders' equity of CN¥548.8m.
ClouDr Group Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2022-07-06. The firm provides medical supplies and software-as-a-service (SaaS) products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescriptions to patients. The firm's product portfolio consists of three major product or service categories. The in-hospital solution mainly includes hospital supplies sales, hospital SaaS and digital marketing services. The pharmacy solution mainly includes pharmacy supplies sales and pharmacy SaaS. The individual chronic condition management solution and others mainly include chronic condition products, premium membership services, as well as insurance brokerage services, advertisement agent services and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 6 Jul 2022
- Employees
- 1,489
- Website
- cloudr.cn ↗
Leadership
Pay as last reported
- Mr. Ming KuangExecutive Chairman of the Board, Chief Executive Officer, Founder, since 2015CN¥16.1m
- Ms. Lili XuChief Financial Officer
- Ms. Yinghui ZuoVice President - Supply Chain and Customer Services, Executive Director, since 2015
- Mr. Jingxu WangVice President - Hospital Business and Development
- Mr. Gang LiHead of Technology
- Ms. Wai Sum FungCompany Secretary, since 2023
- Mr. Khai Meng AngNon-Executive Independent Director
- Dr. Weili HongNon-Executive Independent Director
- Mr. Saiyin ZhangNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ClouDr Group Ltd. provides medical supplies and SaaS to hospitals in Hangzhou with 1,489 employees.
- The company offers in-hospital solutions including hospital SaaS and digital marketing services.
- ClouDr's pharmacy solution includes pharmacy supplies sales and pharmacy SaaS for Zhejiang pharmacies.
Weaknesses
- ClouDr's individual chronic condition management solution includes insurance brokerage services with limited market penetration.
- The company's digital marketing services for pharmaceutical companies face competition in the Health Care sector.
- ClouDr's online consultations and prescriptions face regulatory challenges in China's Health Care market.
Opportunities
- ClouDr can expand its in-hospital solution to other Chinese cities beyond Hangzhou.
- The pharmacy solution's SaaS product has potential for growth in Zhejiang's pharmacy market.
- ClouDr's chronic condition management solution can leverage China's aging population trend.
Threats
- ClouDr faces competition from established players in China's Health Care sector.
- Regulatory changes in China's Health Care market could impact ClouDr's SaaS services.
- Economic downturns in China may reduce demand for ClouDr's premium membership services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.